TGA Approval

AJEMNYE ustekinumab 5 mg / 1.0 mL (130 mg/26 mL) solution for intravenous infusion injection vial (441430)

ARTG ID

441430

ARTG Name

AJEMNYE ustekinumab 5 mg / 1.0 mL (130 mg/26 mL) solution for intravenous infusion injection vial

Sponsor

Amgen Australia Pty Ltd

ARTG Date

May 13, 2024

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Amgen Australia Pty Ltd.

Ingredient Name

Ustekinumab

Empowering clinical research with data-driven insights and AI-powered tools.

AJEMNYE ustekinumab 5 mg / 1.0 mL (130 mg/26 mL) solution for intravenous infusion injection vial (441430) - TGA 批准文号 | MedPath